Major shareholder Duan Lixin of Hunan Jiudian Pharmaceutical (stock code 300705.SZ) has completed a reduction of 1.13% of shares.
Jiudian Pharmaceutical (300705.SZ) announcement, the company's shareholder Duan Lixin, who owns more than 5% of the shares, has reduced his holdings of the company's stock by 55...
Announcement from Hunan Jiudian Pharmaceutical (300705.SZ): Shareholder Duan Lixin, who owns more than 5% of the company's shares, has cumulatively reduced his holdings by 5.595 million shares, accounting for 1.13% of the total share capital. Duan Lixin has decided to terminate the current reduction plan ahead of schedule, and the remaining shares that were not reduced will no longer be reduced during the remaining reduction plan period.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
